Form 4: Century Therapeutics Officer Sells Shares for Tax

Century Therapeutics Officer Gregory Russotti sold 10,076 shares of common stock to cover tax withholding obligations related to RSU vesting.

Summary

• Gregory Russotti, Chief Technology and Manufacturing Officer and Director of Century Therapeutics, Inc. (IPSC), reported a sale of common stock.
• The transaction involved the disposition of 10,076 shares of common stock on March 12, 2026.
• The shares were sold at a price of $2.549 per share.
• The sale was automatic and non-discretionary, executed solely to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Mr. Russotti directly owns 515,427 shares and indirectly owns 92,773 shares through the Gregory Russotti 2021 Family Trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was non-discretionary and solely for tax purposes related to RSU vesting, not an indication of management's confidence in the company.

Future Outlook

NA

Management Comments

• The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Industry Context

StockSavvy.ai notes that "sell to cover" transactions are common for executives receiving equity compensation and are generally not indicative of management's sentiment towards the company's future performance, unlike discretionary sales.

Stakeholder Impact

• Minimal direct impact on shareholders as this is a routine, non-discretionary transaction for tax purposes, not a signal of changing company fundamentals or management sentiment.

Key Dates

Recommendation

This Form 4 reports a routine "sell to cover" transaction by an insider to satisfy tax obligations upon RSU vesting. Such non-discretionary sales do not reflect a change in the insider's view of the company's prospects and therefore do not warrant a change in investment recommendation based solely on this filing. Investors should maintain their current position and look for more substantive operational or financial updates.

Keywords

Century Therapeutics, IPSC, Insider Transaction, Form 4, Stock Sale, Restricted Stock Units, Tax Withholding